Pharmacology
News
Dexamethasone may ‘jeopardize’ benefit of immunotherapy in glioblastoma
Baseline dexamethasone use was the strongest predictor of poor survival in glioblastoma patients receiving a checkpoint inhibitor.
News
IBD patients more likely to stick with vedolizumab than anti-TNF drugs
IBD patients on vedolizumab were significantly less likely to discontinue medication, compared with those on adalimumab or golimumab.
News
FDA OKs osimertinib as first adjuvant drug for NSCLC
The approval is based on results of the ADAURA trial.
Conference Coverage
No benefit of cannabis on depression in pregnant women with OUD
“To our knowledge, this is the first time looking at the impact of cannabis on the specific population of pregnant women with” OUD, said Dr....
Perspectives
COVID-19 vaccines and cancer patients: 4 things to know
News
Gut microbiome influences response to methotrexate in new-onset RA patients
The study’s “results open the possibility to rationally design microbiome-modulating strategies to improve oral absorption of MTX and its...
News
Study links sleep meds and dementia risk in older adults
Routine use of sleeping medications was associated with an approximate 30% increase in risk of dementia.
News
Oral steroids plus PPIs increase osteoporotic fracture risk in RA patients
The risk of fracture in patients taking both drugs rose beyond what was seen in those taking either drug alone in this retrospective, population-...
Conference Coverage
Study found dual-targeted CAR T highly active against relapsed/refractory multiple myeloma
Conference Coverage
Fixed duration ibrutinib/venetoclax appears feasible for some CLL/SLL patients